Christopher N Hurt (Chris Hurt, Christopher Hurt)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 5

Top Topics

Top Venues

British journal of cancer

NPJ precision oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Health technology assessment (Winchester, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah R Brown, Samantha Hinsley, Emma C Hall, Christopher N Hurt, Richard D Baird, Martin Forster, Andrew F Scarsbrook, Richard A Adams
A Road Map for Designing Phase I Clinical Trials of Radiotherapy-Novel Agent Combinations. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (17) (2022)
Douglas Adamson, Jane M Blazeby, Catharine Porter, Christopher N Hurt, Gareth O Griffiths, Annmarie Nelson, Bernadette Sewell, Mari Jones, Martina Svobodova, Deborah Fitzsimmons, Lisette Nixon, Jim Fitzgibbon, Stephen Thomas, Anthony Millin, Tom Crosby, John Nicholas Staffurth, Anthony Byrne
Palliative radiotherapy combined with stent insertion to reduce recurrent dysphagia in oesophageal cancer patients: the ROCS RCT. Health technology assessment (Winchester, England) 25 (31) (2021)
Michelle R Goulart, Jennifer Watt, Imran Siddiqui, Rita T Lawlor, Ahmet Imrali, Christine Hughes, Amina Saad, Joanne ChinAleong, Christopher N Hurt, Catrin Cox, Roberto Salvia, Alberto Mantovani, Tatjana Crnogorac-Jurcevic, Somnath Mukherjee, Aldo Scarpa, Paola Allavena, Hemant Mahendrakumar Kocher
Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma. NPJ precision oncology 5 (1) (2021)
Frances Willenbrock, Catrin M Cox, Eileen E Parkes, Charlotte S Wilhelm-Benartzi, Aswin G Abraham, Robert Owens, Ahmad Sabbagh, Christopher M Jones, Daniel L I Hughes, Tim Maughan, Christopher N Hurt, Eric E O'Neill, Somnath Mukherjee
Circulating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancer. British journal of cancer 124 (3) (2020)
Simon Gollins, Nicholas West, David Sebag-Montefiore, Shabbir Susnerwala, Stephen Falk, Nick Brown, Mark Saunders, Philip Quirke, Ruby Ray, Philip Parsons, Gareth Griffiths, Tim Maughan, Richard Adams, Christopher N Hurt
A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS. British journal of cancer 119 (6) (2018)